XtalPi and Pfizer collaborate on AI-powered drug discovery modeling platform

From Nasdaq: 2025-06-29 21:36:00

XtalPi and Pfizer have expanded their research collaboration to develop a next-generation molecular modeling platform for drug discovery. The initiative aims to improve the accuracy of advanced physics-based methods by integrating them with cutting-edge AI models, optimizing the discovery and development of small-molecule medicines. The companies will focus on developing more accurate predictive models within Pfizer’s proprietary chemical space, empowering small molecule drug discovery and development across a broader range of research applications. XtalPi will deploy its XFEP platform for Pfizer to use in its drug discovery efforts, supporting scientists across diverse scenarios.



Read more at Nasdaq: XtalPi, Pfizer Expand AI-Powered Drug Discovery Collaboration With New Modeling Platform